The Specialist Cancer Centres Program is an initiative that aims to save more lives from cancer and inform where people receive cancer treatment
To achieve this, we collaborate with the health system and use the latest data and evidence to determine and promote hospitals that meet the criteria as a specialist centres.
The Specialist Centres Program involves:
- reviewing the latest research evidence
- analysing data from NSW hospitals and cancer centres
- determining criteria, by cancer type, for specialist centres to be promoted
- seeking advice from clinical advisory groups at every step of the process
Based on this, NSW hospitals and cancer centres that meet agreed criteria are identified and promoted as specialist centres on the Cancer Institute and Canrefer websites.
Bladder cancer specialist centres listed for Sydney and NSW regions
Complex head and neck cancer specialist centres listed for Sydney and NSW regions
Lung cancer specialist centres listed for Sydney and NSW regions
Neuroendocrine cancer specialist centres listed for Sydney and NSW regions
Women in NSW with ovarian cancer, cervical cancer and other gynaecological cancers should be assessed & treated at one of these 7 specialist gynaecological oncology centres.
People suspected of or diagnosed with oesophageal or gastric cancer in NSW should be referred to one of these specialist centres
People suspected of or diagnosed with pancreatic cancer, primary liver cancer, and cholangiocarcinoma in NSW should be referred to one of these specialist centres
Management of adult-onset sarcoma can be complex and requires a team of healthcare professionals with experience in sarcoma treatment
References
1. Currow DC, You H, Aranda S, et al. What factors are predictive of surgical resection and survival from localised non-small cell lung cancer? MJA. 2014;201(8):475–80.
2. Vinod SK, Sidhom MA, Gabriel GS, et al. Why do some lung cancer patients receive no anticancer treatment? J Thorac Oncol. 2010;5(7):1025–32.
3. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128–37.
4. Riaz SP, Linklater KM, Page R, et al. Variation in surgical resection for lung cancer in relation to survival: population-based study in England 2004-2006. Eur J Cancer. 2012: 48(1):54-60.
5. Koppert LB, Lemmens VE, Coebergh JW, et al. Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer.Br J Surg. 2012 99(12):1693-700.
6. Creighton N, Walton R, Roder DM, et al. Pancreatectomy is underused in NSW regions with low institutional surgical volumes: a population data linkage study. Med J Aust. 2017 206(1):23-9.
7. Coupland VH, Lagergren J, Lüchtenborg M, Jack RH, Allum W, Holmberg L, Hanna GB, Pearce N, Møller H. Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004–2008. Gut. 2013;62(7):961–6.